—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Exelixis Inc (EXEL) — Technical state

As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Uptrend stack intact — Trades +20.5% vs the 50-day and +41.8% vs the 200-day average, 0.9% below the 52-week high and +93.6% off the 52-week low. Computed from daily closes. (as of 2026-11-04)
  • Trend: Exelixis Inc trades 20.5% above its 50-day and 41.8% above its 200-day moving average. (as of 2026-11-04)

Exelixis is an oncology company that discovers, develops and sells medicines for hard-to-treat cancers, mainly in the United States. Its main product, CABOMETYX, treats advanced renal cell carcinoma after prior anti-angiogenic therapy, while COMETRIQ addresses progressive medullary thyroid cancer; both derive from cabozantinib, a multi-target kinase inhibitor.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the EXEL overview. Research diary readings, not advice.

Uptrend stack intact

Trades +20.5% vs the 50-day and +41.8% vs the 200-day average, 0.9% below the 52-week high and +93.6% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the EXEL chart & overview · the signal board

FAQ · from the current data · as of 2026-11-04

Quick answers

What is the current Closelooknet signal on EXEL?

Uptrend stack intact — Trades +20.5% vs the 50-day and +41.8% vs the 200-day average, 0.9% below the 52-week high and +93.6% off the 52-week low. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is EXEL above its 50-day and 200-day moving averages?

As of 2026-11-04, Exelixis Inc trades +20.5% above its 50-day and +41.8% above its 200-day average, with the 20-day +12.5% away.

How far is EXEL from its 52-week high?

0.9% below the 52-week high and 93.6% above the 52-week low, as of 2026-11-04.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.